138 related articles for article (PubMed ID: 30141571)
21. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
Kamar N; Ribes D; Izopet J; Rostaing L
Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
[TBL] [Abstract][Full Text] [Related]
22. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
Li T; Qu Y; Guo Y; Wang Y; Wang L
Liver Int; 2017 Jul; 37(7):974-981. PubMed ID: 27943605
[TBL] [Abstract][Full Text] [Related]
24. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
Vallet-Pichard A; Pol S
Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus infection and chronic renal disease: A review.
Goel A; Bhadauria DS; Aggarwal R
Indian J Gastroenterol; 2018 Nov; 37(6):492-503. PubMed ID: 30560540
[TBL] [Abstract][Full Text] [Related]
26. Treating hepatitis C virus in dialysis patients: How, when, and why?
Pagan J; Ladino M; Roth D
Semin Dial; 2019 Mar; 32(2):152-158. PubMed ID: 30475415
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus infection during haemodialysis in India.
Agarwal SK; Dash SC; Irshad M
J Assoc Physicians India; 1999 Dec; 47(12):1139-43. PubMed ID: 11225211
[TBL] [Abstract][Full Text] [Related]
28. Sofosbuvir-based treatment is safe and effective in patients with chronic hepatitis C infection and end stage renal disease: a case series.
Singh T; Guirguis J; Anthony S; Rivas J; Hanouneh IA; Alkhouri N
Liver Int; 2016 Jun; 36(6):802-6. PubMed ID: 26824848
[TBL] [Abstract][Full Text] [Related]
29. Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience.
Muñoz-Gómez R; Rincón D; Ahumada A; Hernández E; Devesa MJ; Izquierdo S; Ortiz M; Hernández-Albujar A; Fernández-Rodríguez C; Calvo M; González R; Lozano M; Castellano G; Fernández-Vázquez I
J Viral Hepat; 2017 Jun; 24(6):464-471. PubMed ID: 27976490
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis.
He YL; Yang SJ; Hu CH; Dong J; Gao H; Yan TT; Liu JF; Yang Y; Ren DF; Zhu L; Zhao YR; Chen TY
Aliment Pharmacol Ther; 2018 Feb; 47(4):526-532. PubMed ID: 29250808
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
[TBL] [Abstract][Full Text] [Related]
32. HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: results from five hemodialysis units in central Greece.
Rigopoulou EI; Stefanidis I; Liaskos C; Zervou EK; Rizos C; Mina P; Zachou K; Syrganis C; Patsidis E; Kyriakopoulos G; Sdrakas L; Tsianas N; Dalekos GN
J Clin Virol; 2005 Sep; 34(1):81-5. PubMed ID: 16009596
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France.
Isnard Bagnis C; Couchoud C; Bowens M; Sarraj A; Deray G; Tourret J; Cacoub P; Tezenas du Montcel S
Liver Int; 2017 Jun; 37(6):820-826. PubMed ID: 28107607
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C therapy: Looking toward interferon-sparing regimens.
Au TH; Destache CJ; Vivekanandan R
J Am Pharm Assoc (2003); 2015; 55(2):e72-84; quiz e85-6. PubMed ID: 25658389
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
36. Acute hepatitis C in patients receiving hemodialysis.
Griveas I; Germanidis G; Visvardis G; Morice Y; Perelson AS; Pawlotsky JM; Papadopoulou D
Ren Fail; 2007; 29(6):731-6. PubMed ID: 17763169
[TBL] [Abstract][Full Text] [Related]
37. [Application of direct antiviral drugs in special patients with HCV infection].
Jiang C; Liu CY; Shao S; Gao YH
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):316-320. PubMed ID: 29996347
[TBL] [Abstract][Full Text] [Related]
38. Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report.
Deng G; Ma J; Shen S; Li Q; Peng L; Meng S; Zhou J; Wu J; Liu D
Transplant Proc; 2016 Nov; 48(9):3120-3122. PubMed ID: 27932161
[TBL] [Abstract][Full Text] [Related]
39. Lack of impact of hepatitis C virus coinfection in end-stage renal disease patients with hepatitis B virus infection.
Moutinho RS; Perez RM; Pace FH; Ferreira AS; Cendoroglo M; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
Transplant Proc; 2005 Jun; 37(5):2080-2. PubMed ID: 15964344
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus infection.
Manns MP; Buti M; Gane E; Pawlotsky JM; Razavi H; Terrault N; Younossi Z
Nat Rev Dis Primers; 2017 Mar; 3():17006. PubMed ID: 28252637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
